Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial: Effect of Ritlecitinib on Patient-Reported Hair Loss in Patients with Alopecia Areata: R. Sinclair et al - Sinclair, Rodney; Mesinkovska, Natasha; Mitra, Debanjali; Wajsbrot, Dalia; Law, Ernest H.; Wolk, Robert; King, Brett (American Journal of Clinical Dermatology, 2025)